SKL-35502

N/A

Report date: 2026/02/02 17:49:13

NME

Base Information

Drug NameSKL-35502

Drug Alias NameSKL-35502SKL35502

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4]

Mechanisms of ActionSingle-photon emission-computed tomography enhancersNeurotensin receptor 1 binders

TargetsNeurotensin receptor 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSK Biopharmaceuticals Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSK Biopharmaceuticals Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A